Join Our Observational Study

Dr. Donald Abrams and Prof. Tamar Peretz.

Interested in participating?

OncoRix’s scientists are preparing an IRB-approved observational study on breast cancer patients at UC Irvine using BREAVIX products.

In this study, we plan to collect six-month data from 120 breast cancer patients who will use BREAVIX products in conjunction with conventional cancer therapy (e.g., chemotherapy).

OncoRix is available through our Californian licensed delivery and retail partners via home delivery or pickup.

Please send us a note via the contact us form if you are a California breast cancer patient interested in participating in our upcoming observational study, and our qualified oncology nurse will contact you.